Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon alpha/beta receptor agonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hepatitis C 3 D006526 ClinicalTrials
Retinal Vasculitis 3 D031300 ClinicalTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 D054198 ClinicalTrials
Kidney Neoplasms 3 D007680 ClinicalTrials
Behcet Syndrome 3 D001528 ClinicalTrials
Lymphoma 3 D008223 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Carcinoma, Renal Cell 3 D002292 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Hepatitis C, Chronic 2 D019698 ClinicalTrials
Leukemia, Hairy Cell 2 D007943 ClinicalTrials
Psoriasis 1 D011565 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 76543-88-9
ChEMBL CHEMBL2108508
FDA SRS 47RRR83SK7